Compare Kenvue Inc. Common Stock (KVUE) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kenvue Inc. Common Stock vs Roivant Sciences Ltd. Common Shares — how do they compare? Kenvue Inc. Common Stock trades at $17.68 (market cap $34.06B), while Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B). The key difference: Kenvue Inc. Common Stock is the larger of the two by market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals.
| KVUE | ROIV | |
|---|---|---|
Market Cap | $34.06B | $24.72B |
Volume | 23,267,228 | 6,279,442 |
Sector | Consumer Staples | Health |
52-Week High | $19.83 | $41.81 |
52-Week Low | $14.11 | $16.04 |
Enterprise Value | $41.56B | $20.99B |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 1 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kenvue Inc. Common Stock
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →
